Literature DB >> 1436541

Needle muscle biopsy with the automatic Biopty instrument.

A M Coté1, L Jiménez, L S Adelman, T L Munsat.   

Abstract

Needle muscle biopsies are less traumatic and easier to do than open biopsies, but their main disadvantage is the small specimen size. One hundred and five patients underwent needle biopsies with a 14-gauge spring-loaded device that guillotines the muscle automatically (Bard Radiology). Fifty patients had more than one muscle biopsy. One hundred and forty-six of 155 specimens contained over 200 muscle fibers, some as many as 500 fibers. Having evaluated various needles, we found the Bard Biopty instrument more efficient than manual needles and open biopsy techniques, and it provides muscle specimens for pathologic interpretation that are comparable with open surgical procedures.

Entities:  

Mesh:

Year:  1992        PMID: 1436541     DOI: 10.1212/wnl.42.11.2212

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  The use of percutaneous needle muscle biopsy in the diagnosis of myopathy.

Authors:  D Lacomis
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Microbiopsies versus Bergström needle for skeletal muscle sampling: impact on maximal mitochondrial respiration rate.

Authors:  M E Isner-Horobeti; A Charton; F Daussin; B Geny; S P Dufour; R Richard
Journal:  Eur J Appl Physiol       Date:  2014-01-22       Impact factor: 3.078

3.  Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.

Authors:  Cristina Chimenti; Luca Padua; Costanza Pazzaglia; Emanuela Morgante; Carlos Centurion; Daniela Antuzzi; Matteo A Russo; Andrea Frustaci
Journal:  Hum Pathol       Date:  2012-03-08       Impact factor: 3.466

4.  Differences in pain perception during open muscle biopsy and Bergstroem needle muscle biopsy.

Authors:  Julius Dengler; Peter Linke; Hans J Gdynia; Stefan Wolf; Albert C Ludolph; Peter Vajkoczy; Thomas Meyer
Journal:  J Pain Res       Date:  2014-11-17       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.